Drug Profile
Pantoprazole - Shiner Pharm
Alternative Names: PantoproLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Shiner Pharm Corp
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Antiulcers; Gastric antisecretories; Small molecules
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Duodenal ulcer; Erosive oesophagitis; Gastric ulcer; Gastro-oesophageal reflux; Helicobacter infections; Zollinger-Ellison syndrome
Most Recent Events
- 12 Feb 2019 Chemical structure information added